Failure of a randomized, double-blind, placebo-controlled study to evaluate the efficacy of H. pylori eradication in H. pylori -infected patients with functional dyspepsia

Su Jin Hong, In Kyung Sung, Jae Gyu Kim, Sang Woo Lee, Suck Chei Choi, Chang Hun Yang, Sang In Lee, Dong Ho Lee, Gwang Ha Kim, Seong Woo Jeon, Moo In Park, Sue K. Park, Byung Joo Park, Sang Young Seol

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

Background/Aims: The role of Helicobacter pylori eradication in patients with functional dyspepsia (FD) is still uncertain. We originally planned a randomized clinical study to observe dyspeptic symptoms after H. pylori eradication therapy. However, we failed to complete the study; therefore, we analyzed the factors that affected the failure of the study. Methods: Interviews and questionnaire surveys were conducted to analyze the factors that induced early termination from the study. Results: Many patients were screened by gastroenterologists at 11 tertiary referral hospitals between July 2009 and August 2010; however, only 4 patients met the enrollment criteria. Most patients who visited our clinics had been experiencing FD symptoms for less than 6 months or were already taking medication. They also demanded to continue taking medications and using other drugs. Only 3 of the 4 patients signed informed consent. Conclusions: The application of the current Rome III criteria to FD is difficult to evaluate in Korean patients with dyspeptic symptoms because of the early medical evaluation. Most Korean patients who were diagnosed with FD by the Rome III criteria did not overcome their fear of being unable to use rescue medications during the study period.

Original languageEnglish
Pages (from-to)468-471
Number of pages4
JournalGut and Liver
Volume5
Issue number4
DOIs
Publication statusPublished - 2011 Dec 1

Fingerprint

Dyspepsia
Pylorus
Placebos
Helicobacter pylori
Informed Consent
Tertiary Care Centers
Statistical Factor Analysis
Fear
Interviews
Pharmaceutical Preparations

Keywords

  • Dyspepsia
  • Helicobacter pylori
  • Symptom

ASJC Scopus subject areas

  • Hepatology
  • Gastroenterology

Cite this

Failure of a randomized, double-blind, placebo-controlled study to evaluate the efficacy of H. pylori eradication in H. pylori -infected patients with functional dyspepsia. / Hong, Su Jin; Sung, In Kyung; Kim, Jae Gyu; Lee, Sang Woo; Choi, Suck Chei; Yang, Chang Hun; Lee, Sang In; Lee, Dong Ho; Kim, Gwang Ha; Jeon, Seong Woo; Park, Moo In; Park, Sue K.; Park, Byung Joo; Seol, Sang Young.

In: Gut and Liver, Vol. 5, No. 4, 01.12.2011, p. 468-471.

Research output: Contribution to journalArticle

Hong, SJ, Sung, IK, Kim, JG, Lee, SW, Choi, SC, Yang, CH, Lee, SI, Lee, DH, Kim, GH, Jeon, SW, Park, MI, Park, SK, Park, BJ & Seol, SY 2011, 'Failure of a randomized, double-blind, placebo-controlled study to evaluate the efficacy of H. pylori eradication in H. pylori -infected patients with functional dyspepsia', Gut and Liver, vol. 5, no. 4, pp. 468-471. https://doi.org/10.5009/gnl.2011.5.4.468
Hong, Su Jin ; Sung, In Kyung ; Kim, Jae Gyu ; Lee, Sang Woo ; Choi, Suck Chei ; Yang, Chang Hun ; Lee, Sang In ; Lee, Dong Ho ; Kim, Gwang Ha ; Jeon, Seong Woo ; Park, Moo In ; Park, Sue K. ; Park, Byung Joo ; Seol, Sang Young. / Failure of a randomized, double-blind, placebo-controlled study to evaluate the efficacy of H. pylori eradication in H. pylori -infected patients with functional dyspepsia. In: Gut and Liver. 2011 ; Vol. 5, No. 4. pp. 468-471.
@article{178f4ca7451f468894bcc47106f20633,
title = "Failure of a randomized, double-blind, placebo-controlled study to evaluate the efficacy of H. pylori eradication in H. pylori -infected patients with functional dyspepsia",
abstract = "Background/Aims: The role of Helicobacter pylori eradication in patients with functional dyspepsia (FD) is still uncertain. We originally planned a randomized clinical study to observe dyspeptic symptoms after H. pylori eradication therapy. However, we failed to complete the study; therefore, we analyzed the factors that affected the failure of the study. Methods: Interviews and questionnaire surveys were conducted to analyze the factors that induced early termination from the study. Results: Many patients were screened by gastroenterologists at 11 tertiary referral hospitals between July 2009 and August 2010; however, only 4 patients met the enrollment criteria. Most patients who visited our clinics had been experiencing FD symptoms for less than 6 months or were already taking medication. They also demanded to continue taking medications and using other drugs. Only 3 of the 4 patients signed informed consent. Conclusions: The application of the current Rome III criteria to FD is difficult to evaluate in Korean patients with dyspeptic symptoms because of the early medical evaluation. Most Korean patients who were diagnosed with FD by the Rome III criteria did not overcome their fear of being unable to use rescue medications during the study period.",
keywords = "Dyspepsia, Helicobacter pylori, Symptom",
author = "Hong, {Su Jin} and Sung, {In Kyung} and Kim, {Jae Gyu} and Lee, {Sang Woo} and Choi, {Suck Chei} and Yang, {Chang Hun} and Lee, {Sang In} and Lee, {Dong Ho} and Kim, {Gwang Ha} and Jeon, {Seong Woo} and Park, {Moo In} and Park, {Sue K.} and Park, {Byung Joo} and Seol, {Sang Young}",
year = "2011",
month = "12",
day = "1",
doi = "10.5009/gnl.2011.5.4.468",
language = "English",
volume = "5",
pages = "468--471",
journal = "Gut and Liver",
issn = "1976-2283",
publisher = "Joe Bok Chung",
number = "4",

}

TY - JOUR

T1 - Failure of a randomized, double-blind, placebo-controlled study to evaluate the efficacy of H. pylori eradication in H. pylori -infected patients with functional dyspepsia

AU - Hong, Su Jin

AU - Sung, In Kyung

AU - Kim, Jae Gyu

AU - Lee, Sang Woo

AU - Choi, Suck Chei

AU - Yang, Chang Hun

AU - Lee, Sang In

AU - Lee, Dong Ho

AU - Kim, Gwang Ha

AU - Jeon, Seong Woo

AU - Park, Moo In

AU - Park, Sue K.

AU - Park, Byung Joo

AU - Seol, Sang Young

PY - 2011/12/1

Y1 - 2011/12/1

N2 - Background/Aims: The role of Helicobacter pylori eradication in patients with functional dyspepsia (FD) is still uncertain. We originally planned a randomized clinical study to observe dyspeptic symptoms after H. pylori eradication therapy. However, we failed to complete the study; therefore, we analyzed the factors that affected the failure of the study. Methods: Interviews and questionnaire surveys were conducted to analyze the factors that induced early termination from the study. Results: Many patients were screened by gastroenterologists at 11 tertiary referral hospitals between July 2009 and August 2010; however, only 4 patients met the enrollment criteria. Most patients who visited our clinics had been experiencing FD symptoms for less than 6 months or were already taking medication. They also demanded to continue taking medications and using other drugs. Only 3 of the 4 patients signed informed consent. Conclusions: The application of the current Rome III criteria to FD is difficult to evaluate in Korean patients with dyspeptic symptoms because of the early medical evaluation. Most Korean patients who were diagnosed with FD by the Rome III criteria did not overcome their fear of being unable to use rescue medications during the study period.

AB - Background/Aims: The role of Helicobacter pylori eradication in patients with functional dyspepsia (FD) is still uncertain. We originally planned a randomized clinical study to observe dyspeptic symptoms after H. pylori eradication therapy. However, we failed to complete the study; therefore, we analyzed the factors that affected the failure of the study. Methods: Interviews and questionnaire surveys were conducted to analyze the factors that induced early termination from the study. Results: Many patients were screened by gastroenterologists at 11 tertiary referral hospitals between July 2009 and August 2010; however, only 4 patients met the enrollment criteria. Most patients who visited our clinics had been experiencing FD symptoms for less than 6 months or were already taking medication. They also demanded to continue taking medications and using other drugs. Only 3 of the 4 patients signed informed consent. Conclusions: The application of the current Rome III criteria to FD is difficult to evaluate in Korean patients with dyspeptic symptoms because of the early medical evaluation. Most Korean patients who were diagnosed with FD by the Rome III criteria did not overcome their fear of being unable to use rescue medications during the study period.

KW - Dyspepsia

KW - Helicobacter pylori

KW - Symptom

UR - http://www.scopus.com/inward/record.url?scp=81855216309&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=81855216309&partnerID=8YFLogxK

U2 - 10.5009/gnl.2011.5.4.468

DO - 10.5009/gnl.2011.5.4.468

M3 - Article

VL - 5

SP - 468

EP - 471

JO - Gut and Liver

JF - Gut and Liver

SN - 1976-2283

IS - 4

ER -